In December 2025, the FDA approved the Wegovy pill (once-daily oral semaglutide 25 mg) as the first oral GLP-1 receptor agonist therapy approved for weight management, with Novo Nordisk announcing launch in early January 2026
In addition, demographic factors such as age, gender, duration of scars, type of acne scar, and Fitzpatrick skin type were found to influence treatment outcomes, highlighting the importance of patient-based approach in managing acne scars
Editors Note: In addition to name-brand GLP-1s, some of the companies on this list may offer compounded options
NNMT is expressed most highly in human liver (RPKM 188.3), followed by the appendix (RPKM 69.3) and approximately ten other tissues, with a biased expression pattern
This initial assessment helps PlexusDx identify whether you're a candidate for compounded semaglutide injection (at $189/mo month-to-month, or from $149/mo on the 6-month plan), oral options, or combination therapies like GLP-Squared
Water, adequate fiber, and gentle daily movement help
